Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Oncogene
|
June 23, 2001
Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance
K Friedrich, T Wieder, C Von Haefen, et al.
International Journal of Cancer
|
August 15, 1994
Apoptotic cell death induced by a mouse-human anti-APO-1 chimeric antibody leads to tumor regression
L R Coney, P T Daniel, D Sanborn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases
I Sturm, C H Köhne, G Wolff, et al.
International Journal of Cancer
|
March 16, 1995
Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis
R C Bargou, P T Daniel, M Y Mapara, et al.
Cell Death & Disease
|
May 25, 2013
Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode
B Gillissen, A Richter, A Richter, et al.
Oncogene
|
December 7, 2005
Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells
J Wendt, S Radetzki, C von Haefen, et al.
Leukemia
|
June 1, 2002
Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia
A G Bosanquet, I Sturm, T Wieder, et al.
British Journal of Cancer
|
April 7, 1998
Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity
C H Köhne, P Thuss-Patience, M Friedrich, et al.
Blood
|
March 9, 2000
A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes
A Löffler, P Kufer, R Lutterbüse, et al.
Oncogene
|
April 26, 2006
Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo
P Marini, S Denzinger, D Schiller, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Oncogene
|
June 23, 2001
Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance
K Friedrich, T Wieder, C Von Haefen, et al.
International Journal of Cancer
|
August 15, 1994
Apoptotic cell death induced by a mouse-human anti-APO-1 chimeric antibody leads to tumor regression
L R Coney, P T Daniel, D Sanborn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases
I Sturm, C H Köhne, G Wolff, et al.
International Journal of Cancer
|
March 16, 1995
Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis
R C Bargou, P T Daniel, M Y Mapara, et al.
Cell Death & Disease
|
May 25, 2013
Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode
B Gillissen, A Richter, A Richter, et al.
Oncogene
|
December 7, 2005
Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells
J Wendt, S Radetzki, C von Haefen, et al.
Leukemia
|
June 1, 2002
Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia
A G Bosanquet, I Sturm, T Wieder, et al.
British Journal of Cancer
|
April 7, 1998
Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity
C H Köhne, P Thuss-Patience, M Friedrich, et al.
Blood
|
March 9, 2000
A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes
A Löffler, P Kufer, R Lutterbüse, et al.
Oncogene
|
April 26, 2006
Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo
P Marini, S Denzinger, D Schiller, et al.
Page
of 7